Hospital-acquired infections: a cost estimation for CLABSI in Portugal by Fiorentino, Francesca
A Work Project, presented as part of the requirements for the Award of a Master Degree in 
Economics from the NOVA – School of Business and Economics. 
  
 
Hospital-acquired infections: a cost 
estimation for CLABSI in Portugal 
Francesca Fiorentino 14000565 
 
A Project carried out on the Economics of health and health care 





Hospital-acquired infections (HAIs) are defined as system infections that neither were 
present nor in incubation when the patient was hospitalized. We provide an estimation of 
most extra direct costs (those associated to longer hospitalization), length of stay and 
mortality rate due to the onset of a particular HAI, the central line associated bloodstream 
infection (CLABSI) in a 322-bed Portuguese hospital between 2009 and 2012.  
Main outputs drivers are identified, then a matching estimator is implemented in order to 
estimate the average treatment effect (ATE) for infected patients. ATE was estimated by 
using two different matching criteria accounting both for personal characteristics and health 
status of the patients. Results are significant and in line with literature: CLABSIs result in 
average extra costs per patient between 7930.84€ and 11,230.42€; an extra average length of 
stay between 20 and 25 days; and expected difference of mortality rate between 8.58% and 
18.18%. Findings- confirming expectation of higher costs associated due to these infections- 
have important policy implications such as decision of investing in prevention campaigns. 
Indeed, CLABSIs are considered highly preventable infections such that there is great 
potential of reducing their incidence.  
1. Introduction  
Nosocomial infections -or hospital-acquired infections (HAIs) - are defined as system 
infections that were neither present nor in incubation at the patient first hospitalization (see 
Appendix 1 for details regarding the data collection criteria). Here only laboratory-confirmed 
infections will be considered.   
The onset of nosocomial infection “complicates the delivery of patient care, contributes to 
patient deaths and disability, promotes resistance to antibiotics, and generates additional 
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expenditure to that already incurred by the patient’s underlying disease.”1As such, both 
direct and indirect costs occur: the former referring to longer hospitalization time and more 
intensive use of resources; while the latter refers to increased potential of patient death, 
possible reduction in quality of life, and further opportunity costs of working and relatives’ 
opportunity cost of visiting and assisting (Table 1). 
Table 1: Direct and indirect costs associated to HAIs 
Direct Costs Indirect Costs 
a. Longer hospitalization time 
b. More intensive use of resources 
b.1 Drugs 
b.2 Health Professional time 
c. Increased potential of death 
d. Possible reduction of patient’s quality of life 
e. Extra opportunity-cost of patient working 
f. Relatives’ opportunity-cost of visiting and 
assisting 
 
This work has the goal of verifying whether in those Portuguese hospital considered there 
are significantly different outputs attributable to a specific laboratory confirmed HAI, central 
line associated bloodstream infections (CLABSIs).  
This sub-group of nosocomial infections are of particular interest because they are considered 
the most reducible among hospital-acquired infections:2 medical researchers claim that a 
target of zero cases is realistic for this specific type of nosocomial infections.3 Correct 
estimation of their associated costs have important policy implications and information can 
be used in order to implement new payment systems with better incentives for HAIs 
prevention or on the decision to finance new prevention programs. The analysis aims at 
                                                     
1 WHO (2005) 
2 Umsheid et al. (2005) 
3 Harnge A. Sophie (2007) 
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identifying these costs using a tridimensional approach analyzing three outputs: the 
difference in costs of care; length of stay (LOS) and mortality rate between infected and not 
infected patients will be estimated. The analysis is limited by studying only the most relevant 
part of the direct costs associated to longer hospitalization time (point a in Table 1) within a 
Portuguese health center; however findings are significant and align with the expectation of 
higher costs associated due to these infections. 
In the hospital considered, the estimated direct costs of CLABSIs range between 714,851.4€ 
and 1,000,424€ per year (2.6%-3.7% of total hospital costs) ; extra average length of stay between 
20 and 25 days; and expected difference of mortality rate is between 8.6% and 18.2%. 
These costs may reduce to zero by investing in prevention campaigns aimed at physicians 
and care professionals: nevertheless a positive rate of infection may still be economically 
efficient if the needed investment less than compensate its economic benefits in terms of 
infection control. Further studies are needed in order to assess the cost-effectiveness of 
prevention campaigns, but this study shows that there are consistent resources that may be 
saved.  
The work will first illustrates a brief literature review with the main results of other authors 
and the relevance of the topic (section 2); in section 3 the database used will be presented 
and  methodology of estimation will be illustrated in section 4 followed by the results (section 
5), discussion (section 6) and conclusions (section 7).     
2. Literature review 
Recent literature confirms the extra costs associated to the presence of nosocomial infections; 
however results vary significantly between studies. Defez (2010) estimates cost differentials 
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between €574 and €2,421 (depending on the group of infection) in a 1,198-bed hospital in 
Nimes, while Orsi et al. (2004) estimate an average difference of €15,413 in a 2,000-bed 
hospital in Rome. Peng et al. (2006) associate a 10% mortality increase to infected patients 
in the Intensive Care Unit of 177 Pennsylvania hospitals, while Rosenthal et al. (2003) 
estimate that fatality is 24.6% higher among bloodstream-infected patients in Surgical 
Intensive Care Units of three hospitals of Buenos Aires. Finally, the extra length of stay 
associated to blood-stream infections ranges from 9.9 days (Vrijens, 2009) to 19.1 days (Orsi 
et al., 2002). 
The European Center for Disease Prevention and Control (ECDC) released data from a 2011-
2012 study,4 where the average incidence of all HAIs in Europe 27 is estimated as 5.7% (only 
data from eight5 countries were not considered representative), ranging from 2.3% in Latvia 
to 10.8% in Portugal. In 2011 the United States Center for Disease Prevention and Control 
(CDC) reported6 that in USA the percentage was lower at approximately 5%. In USA, an 
incentive to prevention of such infections resented itself in 2008 when public insurers started 
denying reimbursement for expenses related to the most preventable nosocomial infections, 
hospitals became responsible for these costs. 7 
The most numerous nosocomial infections are respectively: Ventilator-Associated 
Pneumonia Infections (VAP); Surgical Site Infection (SSI); Urinary Tract Infections 
(CAUTI) and Central Line-Associated Bloodstream Infections (CLABSI).  Their overall 
                                                     
4 ECDC (2013) 
5 Austria ; Croatia , Czech Republic, Estonia , Norway , Romania, Denmark and Sweden  
6 Dudeck et al. (2013) 
7 Stone et al. (2010) 
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prevention rate is estimated between 10% and 20%, and their incidence rate in 2011-2012 is 
summarized in Table 2: 
Table 2: Prevalence rate of nosocomial infections by group 
VAP SSI CAUTI CLABSI OTHERS All HAIs 
23.50% 19.60% 19% 10.60% 27.30% 5.70% 
29% 16% 23% 8% 24% 10.80% 
 
It can be noticed that in Portugal there is both a much higher prevalence of HAIs and a 
different relative weight of groups of infections with respect to the European average (Europe 
27).  
In the USA, the first literature related to the preventability of HAI’s was published in the 
early 1980’s under the work of Haley et al. (1980): “The SENIC Project. Study on the efficacy 
of nosocomial infection control. Summary of study design.” This study attempted to quantify 
the impact of these infections and analyzed the Government’s prevention program which had 
been implemented in American hospitals since 1974. English speaking countries including 
those in North America and the United Kingdom began studying the extra costs incurred due 
to HAI’s beginning in 1999, 8 while European literature in this area only began really 
contributing in recent years. 9 The interest in this topic peaked in Europe in response to the 
rise of patient safety concerns and recent economic crisis. In particular, in 2004 a patient 
safety program was promoted by the World Health Organization – The World Alliance for 
Patient Safety – with the purpose to “coordinate, facilitate and accelerate patient safety 
                                                     
8 Umsheid et al. (2011) and Pronovost et al. (2006) 
9 Tarricone et al. (2010) and Defez et al (2008) 
Source: ECDC 2013 
pg. 6 
 
improvement around the world”. 10 As part of this initiative, in 2005 the Global Patient Safety 
Challenge “Clean Care is Safer Care” was launched, aimed at raising patient awareness 
about health rights and mobilizing policy makers for the introduction of guidelines with 
stricter prevention rules.  
Additionally, European public health care provision is currently under extraordinary pressure 
due to both the general decrease in financing, as a consequence of public spending reductions, 
and to increasing costs whose main driver is the introduction and adoption of new 
technologies. Subsequently, a greater concern is arising with regards to the efficiency of 
public financing and production. 11 It is in this context that this analysis examines HAIs in 
Portugal. 
3. Data  
The study is based on data collected by the Hospital São Francisco Xavier (SFXH), part of 
the Lisbon Occidental Hospital Centers (CHLO) in Portugal, a 322-bed teaching hospital.12 
Seven wards of discharge with 165 beds in total have been included in this analysis, and 
comprise surgery, orthopedics, hematology, Intensive Unity Care (UCIP), Surgery Intensive 
Unity Care (UCIC), medicine III, and medicine IV (See Appendix 2 for detailed hospital 
characteristics).  
The health center collects information of all hospitalizations, diagnostics, treatments and 
some individual characteristics of the patients according to the national standards of 
Diagnostic Related Groups (DRG) records.13  
                                                     
10 WHO news release (2011)  
11 Glied and Smith (2011) Chapter 38 
12 356 in 2009, 3317 in 2010 and 359 in 2011 
13 International Statistical Classification of Diseases and related Health Problem ICD-09 
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The Infection Control Committee provided the access to data related to patients with CLABSI 
infected since 2009, with data on to other HAI’s available only for 2012. The accounting 
department provided all hospital center costs and balance sheets.   
Since these data are classified as sensitive, an authorization was needed to access to the 
information. According to the Portuguese regulation,14 the Health Ethics Commission must 
provide consent for the data treatment- the authorization was received on the 3th of October, 
2013.   
The time frame for this study is the 2009-2012 period, although there is no information 
regarding the onset of other HAIs but CLABSIs from 2009 to 2011. The sample counts 
16,200 observations; among which 194 caught CLABSI.15  
It can be noticed, that SFXH has much lower incidence, only 1.7%,16 of CLABSI than the 
average national prevalence according to ECDC point prevalence estimation presented above 
(8%).    
3.1 Episodes 
Each observation in the sample has with it associated two main codes: the episode number 
(Id) which is a unique identification; and the procedure number (Patno) which is associated 
to each patient, and thus repeats when this patient returns to the hospital.  
The only personal characteristics specified are gender and sex; there is no information 
regarding the employment status, income or the civil status (married, cohabitation, unmarried 
or divorced). 17 Clinical facts are more detailed, and there is complete data regarding the date 
                                                     
14 Law n.68/98 
15 281 CLABSI episodes were recorded in the hospital, but only 194 were discharged in the seven wards   
considered.  
16 Considering the 281 cases of CLABSI on the 16,200 patient discharged  
17 it could be possible to obtain this information using the social card number, variable: N_social 
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of admission and discharge; time of permanence, whether patients had been transferred to or 
from another health center; admission type (scheduled or not); wards admitted to by the 
patient including ward of discharge, and the correspondent time of entry and exit from each; 
primary and secondary diagnosis; medical procedures performed; and DRG codification.  
Using existing variables, new ones were created to better fit the analysis. The patno 
associated to each patient makes it possible to account for the number of times a patient 
returned to the Hospital in the last four years (N_separations). The number of separations for 
patients detects those returning to this same hospital and being dismissed in one of the seven 
wards under consideration in this study. 
The length of stay in each ward (LOSwardX) is calculated starting from the days in which a 
patient has been transferred from one ward to another until being discharged. This 
information is instrumental for computing the cost per patient as will be illustrated.  
With more than 1,000 different main diagnostics, a simplification procedure was done based 
on the coding structure of the diagnostics. More general diagnostic classifications were 
considered using the first two digits of the hierarchical structure. This generalization has 
some evident limitations. For instance, the classifications of endocrines diseases is such that 
all belong to the same group at the two digit level, and thus anemia is comparable to 
lymphadenitis in this methodology, which may contradict standard medical knowledge. 
Similarly, the DRGsimple had been generated by eliminating the last digit of the DRG total 
code: last digit captures either the disease grade of complexity or the presence of 
complications. Since nosocomial infections are always coded as complication, it is 
impossible to establish whether the attribution of complication would have occurred without 
the onset of HAIs or not. Therefore the shortened code should not differentiate between two 
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individuals with equal morbidity whose difference is only the onset of the HAI. The database 
was then enriched with the information of the Committee of Infection Control: infected 
patients were identified. As mentioned before, the database did not include all the discharged 
patients of the hospital, but only who was discharged in the seven wards considered. For this 
reason there are 87 patients who were infected in the hospital, but were not present in the 
database (in the hospital CLABSI episodes are 281, while in the database there are only 194).   
The following Table resumes the available information regarding patients and their 
hospitalization.  
Table 3: Database Variables 
Variables Description Details 
Id Episode identification number   
Patno Patient identification number   
Sex Gender of patient   
Age Age of patient   
N_social Social security identification number 
No access to the 
information 
Date_admission  Date of admission    
Date_discharge Date of discharge   
LOS Total length of Stay in the Hospital    
Servalta Ward of discharge 
Information for seven 
wards 
adm_tip  Admission type Scheduled or not scheduled 
ward1; …; ward20 Wards where patient stayed 




Length of stay per ward It ranges from 1 to 302 
diag_1;…; diag_20 Other diagnosis, but main 
More than 1,000 types of 
diagnostics 
Diagp Main diagnosis 
More than 1,000 types of 
diagnostics 
proc_1;…; proc_20 N. of  procedures patient undertook   
Dummy_operation 





Tipo_alta Type of discharge 
To home, to other hospital, 
death 
Mdc Main diagnostic group   
DRG Diagnostic related sub-group   
DRGtotal Diagnostic related group  
Merge of MDC and GCD: 
419 different combinations 
WLOSMAX Ward where the patients stayed longer   
n_separations 
Time of separation for the same patient in 
the same Hospital 
  
n_proc Number of procedures performed   
n_diag 
Number of diagnostics excluding the 
diagnostics related to HAIs 
It ranges from 1 to 20.  
grupo_diagp Grouping of main diagnosis 97 main diagnosis groups 
DRGsimple Simplification of DRG 130 DRG simplified 
 
3.2 Costs 
Hospital accounting is organized by specialty wards and distinguish between ambulatory and 
hospitalization cost. Each specialty ward may correspond to one or more operational wards. 
Of importance is the ambulatory versus hospitalization cost for two different reasons: firstly 
because only hospitalized patients may potentially acquire HAIs, and secondly because only 
hospitalized individuals are registered in DRG tables.  
Hospital balance sheets include information on costs and expenses for all surgical operations. 
Since the number of operations per year is unknown and not all patients were present in the 
database, attributing proportional surgical expenses to each patient is not possible. 
Consequently, total cost of care for patients who underwent an operation are significantly 
underestimated.      
This hospital consults independently for their accounting work in collaboration with other 
hospital members of CHLO. As such, patient transfers between hospitals are considered 
within the same care center. Consequently in this database, there is information on other 
wards with CHLO hospitals outside of SFXH whose costs are unknown. In order to include 
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these in the cost estimation, SFXH costs per ward were considered a proxy for corresponding 
wards in other hospitals. In other words, the cost of hospitalization in a cardiology ward of a 
CHLO hospital is assumed equal to the cardiology ward of SFXH. When no specific ward 
existed to refer to, the average daily cost of the rest of the stay was imputed to the missing 
values. This approximation was required for 200 patients (6.3% of the total). Both variable 
costs (costs of goods and material consume and the supply of external services) and fixed 
costs (financial losses and costs, administrative equipment, amortization and extraordinary 
gains and losses) have been proportionally attributed among all wards by the hospital 
accounting department. 
For each ward considered, total costs (with the exception of extraordinary gains and losses) 
have been divided by the number of patients and their number of days spent in the ward in 
order to compute an average unitary (per day and per patient) cost by ward. Unitary cost was 
then combined with information regarding the length of stay in each ward (LOS in ward1; 
…; LOS in ward20), and an approximation of each patient’s financial burden was obtained. 
Yearly costs from 2009-2012 are inflation adjusted according to National Statistics Institute 
statistics.18 Results however must be interpreted keeping in mind the cost allocation – in 
particular the fixed cost allocation proportional to each patient. 
Furthermore, it must be noticed that -with this available information- it is not possible to 
attribute higher costs to patients who are consuming more intensively hospital resources19 
within a same ward. Such that a patient hospitalized in surgery ward will have a daily cost 
higher than a patient in orthopedics, but –within the surgery ward- the daily cost of a critical 
                                                     
18 The yearly changes in the general level of prices of goods and services bought by private households.  
19 Such as higher drugs consumption or more physicians’ and care professionals’ time.  
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episode will equal the cost of a simpler episode. Therefore only costs due to longer LOS 
(point a in Table 1) may be attributed to CLABSIs, while those associated to more intensive 
use of resources (point b in Table 1) are not accounted.  
4. Methodology  
Only patients admitted for at least two days have been considered since -by definition- 
hospital-acquired infections may appear at least after two days of stay.  Inbound or outbound 
patient transferred from other health facilities are excluded since information relative to care 
received before or after is not available, and an accurate estimation of outputs was not 
possible. Treatment costs of under-18 patients are expected to significantly differ from the 
others patients and none of them caught a CLABSI, therefore 88 observations were dropped 
because of age criteria.  
A further 96 patients were excluded that spent the majority of their stay either in wards not 
relevant for this study (Gynecology, Obstetrics; Plastic Surgery and Oncology) or without a 
correspondent specialty ward in HSFX (Endocrinology; Infection diseases; 
Otorhinolaryngology; Pneumology and neck and head ward) were left out. By applying all 
these restrictions, 3,053 observations were excluded from the database. The finalized 
database accounts for 13,147 individuals- 190 with CLABSI- of which 180 had cost 
approximated using the average cost per day of the known cost of stay.   
Population has been divided in two groups: not infected – control group- and infected by 
CLABSI- treated group. This grouping allows the analysis of central catheter bloodstream 
infections with respect to the uninfected population (hence the population infected by other 
nosocomial infection in 2012 is not considered).  
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The following Table summarizes the population characteristics for both these groups:    
Table 4: Population Characteristics 
  All population Not Infected Infected by CLABSI 
Proportion 100% 98.57% 1.43% 
Age  67.4 67.34 69.9 
  Min 18 18 22 
  Max 107 107 100 
Women 57.0% 57.2% 43.5% 
N. separations    
 
One or two 88.97% 88.48% 81.05% 
Three or four 6.09% 6.05% 8.42% 
Five or more 5.54% 5.47% 10.53% 
N. of days pre-operation 3.66 3.16 13.05 
  Min 1 1 1 
  Max 142 108 142 
N. of procedures 8.1 8.01 15.22 
  Min 1 1 1 
  Max 20 20 20 
Admission type    
  
Scheduled 25.1% 25.3% 9.4% 
Not Scheduled 74.9% 74.7% 90.6% 
N. of diagnosis 6.6 6.5 9.95 
  Min 1 1 1 
  Max 20 20 20 
 
This section will proceed in two estimation phases: the identification of relevant explanatory variables 
of the outputs taken into account; then the presentation of the matching estimator -as best alternative- 
and the matching criteria selected. 
    
4.1 First Phase: identification of relevant variables 
Preliminary analysis begins by testing the difference in outputs among the treatment and 
control groups, in order to validate the meaningfulness of the research question.  
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Of the three outputs considered- mortality rate, length of stay (LOS), and cost of care- the 
following figures show clear differences in output for patients with CLABSI (the treated 
group). This is consistent with the literature where populations with CLABSI are 
characterized by higher costs, LOS, and mortality rates. 




Statistical inferences are conducted in the form of a t-test, Chi-Square test, Ranksum, and 
median test. Results confirm the graphical intuition (Graph 1 and 2) with the null hypothesis 
of equality not accepted and corresponding p-value of zero. The distribution of outputs and 
Table 4, which summarizes population characteristics, show the differences between infected 
and non-infected groups. Both groups have comparable minimum and maximum output 
values, and the similar range allows for meaningful comparisons among groups. 
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The regression confounders are examined for the three outputs – LOS, probability of death, 
and costs.20 These outputs are regressed on variables that may reflect the complexity of the 
episode. Dependent variables were regressed on age, gender, ward, type of admission 
(scheduled or not scheduled), number of separations in the last four years, number of 
diagnostics and the presence of CLABSI.  
The number of separations, variable n_separations, is expected to reflect the risk level of the 
patients, because returning several times for care may result from a weaker health status.  
Among independent variables is included the type of admission, which serves as a proxy for 
whether a patient was admitted with urgency (non-scheduled).Non-scheduled hospital 
admissions are expected to have relatively worse outputs compared to patients admitted for 
scheduled appointments. Since the treatment of CLABSI does not determine the use of 
surgery, an indicator variable for the presence of surgical intervention is also included as an 
independent variable. 
The number of diagnostics informs on the complexity of the episode and is considered a 
determinant of outputs. Although diagnostics are expected to be significant, they are too 
numerous to be used outright as an explanatory variable since it is discrete non-ordinal 
variable that takes over 1,000 values or -at minimum- 97 if simplified. In order to account 
for the different classes of diseases by proxy, the ward were the patient spent the majority of 
his/her stay is used. Operative wards were categorized in five groups: surgical; orthopedics; 
general medicine; intensive care units and hematology (see Appendix 3 for the specification 
                                                     
20From here on, when referring to costs, it is meant approximated and adjusted for inflation costs 
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of wards assigned to each category). Within each group, it is expected that patients have 
comparable diseases and diagnostics. 
The time spent in a hospital is the major determinant of costs, nevertheless it is not used as 
explanatory variable since it is endogenous given the methodology we used to compute them. 
Further, the number of procedures performed during hospitalization is excluded since 
concerns of multicollinearity arise with infected patients receiving more intensive care than 
others.  
When regressing on LOS variable and costs, only not deceased population is included: this 
is because HAIs may lead to a premature death, and the inclusion of deceased individuals 
may lead to inconsistent results.21   
Three types of regressions are used for the given explanatory variable. When regressing on 
cost an OLS is used, on mortality rate a logistic model is used, and when LOS a negative-
binomial. In the case of LOS, an over-dispersion problem has been detected (see Appendix 
4), and a negative-binomial model is preferred to a Poisson.22   
Table 5: Regression of outputs 
  Costs LOS Pr. of surviving 
  (OLS) (NBD) (Logistic) 
Age 30.08*** 0.0006*** 0.0421*** 
Female 363.3* -0.0456*** -0.257*** 
CLABSI 18265.8*** 1.177*** 1.434*** 
N. separations -0.134**  217.3*** 
N. diagnostics 1.229*** .  
Not Scheduled admission 2425.1*** 0.691*** 1.522*** 
                                                     
21 Laupland et al. (2006) and Orsi et al. (2002) 
22 Cameron and Trivedi (2005) 
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Medicine 613.4* -0349*** 0.596*** 
Orthopedics 72.91 -0.012 -0.325* 
Intensive Care Unit 12899.4*** 0.373*** 6.257*** 
Hematology 18370.4*** 0.216*** 1.401*** 
Surgical Interventions 2434.2*** 6.086***  
Constant -2777.8*** -5.756*** -7.692*** 
N 11934 11934 13147 
Adj. R-sq 0.19   
Pseudo R-sq  0.056 0.343 
 
*** P-value≤0.01 **p-value≤0.05 *p-value≤0.1 
Note: Surgery is the baseline ward in the regression 
 
As expected, the presence of CLABSI is significant for all outputs, and outputs are worse for 
infected patients. Furthermore, in all regressions age is highly significant and positive and 
older individuals tend to have higher costs of care. Females on average have higher costs, but 
shorter length of stay and reduced probability of death relative to males. 
The negative relation of n_separations in the regression on cost is counterintuitive, but 
according to the hospital health professionals this may be justified by economies of 
experience – some tests may not be repeated and more information may be available since 
the patients’ recovery in the same hospital during their stay. When regressing on costs and 
LOS the ward where the patient spent the most amount of time is more significant than the 
ward of discharge, while when regressing on mortality rate the opposite was found.  
4.2 Second Phase: implementation of matching estimator 
Following the results of the preliminary analysis, matching estimators were chosen as the 
means to proceed. Regressions results in Table 5 show that there are several determinants for 
the outputs of interest while Table 4 and the distributions in Graph 1 and 2 signal different 
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risk profiles among infected and non-infected groups. Matching estimators is expected to 
reduce the heterogeneity bias due to differences across the population. It is expected that 
infected patients have lower outputs both due to their weaker health status and nosocomial 
infections. 
The second phase of the analysis begins with the choice of matching criteria. When selecting 
criteria there is a statistical trade-offs. If many restrictive rules are set, concerns regarding a 
possible “selection bias” may arise while if few restrictions are set an “omitted variable bias” 
may affect the results. In the former case, the matched sample loses its representativeness, 
while in the latter other relevant cofounders are potentially excluded. 23 When control 
observations are significantly larger than treated observation, as is the case, selection bias is 
expected to converge to zero. 24 
In order to account for the severity of illness, the diagnostic grouping together with the ward 
where the LOS is the longest are considered as strong requirement as the matching of the 
simplified DRG classification. These criteria were summed to the explanatory variables in 
regression resumed in Table 5. The deceased population was excluded when matching costs 
and LOS, for the same reason they were excluded from the regressions. Since surgical 
intervention was selected as matching criterion, the problem of under-estimation of costs for 
operated patients will be removed since operated individuals will be compared only with 
other operated individuals. Surgical intervention is not imputable to the onset of CLABSI 
(but it may be the case for other nosocomial infections), hence the inclusion of this matching 
criterion should not affect the estimation results.  
                                                     
23 Graves et al (2009)  
24 Imbens and Wooldridge (2009)  
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A single match is preferred to multiple matching, and the sample is large enough to expect a 
reasonable loss in precision.25 The estimation also allows for heteroskedasticity and will be 
bias-corrected for age, number of separations, and number of diagnostics (the only 
continuous matching criteria selected). Other covariates always found exact matching since 
they are discrete. The matching criteria are listed as follows: 
Table 6: Matching criteria 
 
In order to verify the validity of the estimation, the matched population must be compared. 
Matching estimators aim at eliminating the effect of the other factors influencing the 
difference in outputs between the control and the treated group. T-test, Chi-square test, 
Ranksum and median test have been performed on the characteristics of the matched 
population used as matching criteria and validity of the estimation was confirmed given that 
                                                     
25 Imbens and Woolridge (2009) 
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all the matching criteria were never significantly different among the control and the 
treatment group.   
5. Results 
Table 7 highlights the estimation results. The figure illustrates two estimation procedures 
with odd rows (1, 3 and 5) using main diagnostic grouping and ward of longest stay (or 
dismissal) while even rows (2, 4 and 6) using simplified DRG code.    
When matching for estimating average treatment effect (ATE) of LOS and costs, the 
observation of patients hospitalized for the majority of time in Orthopedics (3354 patients) 
were excluded. This is because when regressing this ward on the two outputs its coefficient 
was found not significant (see Table 5).  
Table 7: Matching results 














Cost (1) 7930.84 0 3615.73 12245.96 9793 108 48.44% 
Cost (2) 11230.42 0.001 4333.86 18126.98 9793 108 46.78% 
LOS (3) 19.74 0 10.27 29.21 9793 108 38.18% 
LOS (4) 24.60 0 14.31 34.90 9793 108 33.57% 
Mortality 








The results appear to be consistent and the differences between both methods non-significant 
since the average treatment effect of even rows is always included in the 95% Confidence 
Interval of odd rows.  
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Last column shows the percentage of treated patients that find a perfect matches: it can be 
seen that between 32% and 45% infected patients have been perfectly matched, therefore 
concerns regarding “selection bias” are moderate.  
Bloodstream nosocomial infections result in average extra costs between 7,930.84€ and 
11,230.42€ per infected patient; an extra average length of stay between 20 and 25 days; and 
expected difference of mortality rate between 8.58% and 18.18%.  
The results above have great relevance: they show that there is the possibility of consistent 
savings by reducing nosocomial infections. 
Nevertheless average treatment effect may not be interpreted as a direct saving in case of 
zero-infections since both fixed and variable direct costs are accounted for. The actual short-
term saving would result in the reduction of only the variable costs, while fixed costs may be 
recovered only in the medium-long term. Still non-recoverable costs may find a more 
efficient use meaning further immediate saving to be summed to the marginal cost reduction.   
6. Discussion 
Results are significant and in line with literature (briefly presented earlier), nevertheless the 
confidence interval is quite extended. Several factors may be the cause of the variance 
between results. In first place, it has not always been possible to control for other nosocomial 
infections different from CLABSI because only data of 2012 were made available: hence it 
may be that a patient infected by CLABSI is matched with a patient infected by another HAI. 
These result in an under-estimation of the negative outputs due to the morbidity. Secondly, a 
patients characteristics may be correlated with outputs, such as civil and employment status, 
and this information was not made available. Since social security card number is registered, 
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it may be possible to access this information following the approval of the appropriate 
authorities. Finally, some important medical risk-factors were not recorded: for instance, the 
insertion of catheter and for critically ill patients26 or admission classifications scores (such 
as APACHE or SAPS score). This may be a relevant indicator of health status at taken 
admission time when the probability of being infected are equal for all patients and would 
have been included as a matching criteria of ICUs.27  
A limitation of this study is that the cost differential identified cannot be interpreted as an 
immediate monetary benefit for the insurer in case of complete eradication of bloodstream 
nosocomial infections. Fixed resources may find a different-more efficient- use whether freed 
and the insurer expenses may28 increase if the investment in prevention was equal to the 
estimated cost differential.  
Therefore, possible further studies may focus on the marginal costs of such infections: 
average treatment effect of costs may consider only laboratory expenses; extra drugs 
expenses; extra administrative costs; value of higher risk of mortality, costs of lower quality 
of life, extra opportunity cost of working and relatives’ time for visiting and assisting. Here, 
marginal costs may be directly compared with the costs of implementing infection control 
campaign.  
7. Conclusions 
It was estimated that in SFXH bloodstream nosocomial infections result in average unitary 
extra costs attributed to longer LOS between 7,930.84€ and 11,230.42€; an extra average 
                                                     
26 Warren (2006) 
27 Laupland et al. (2006) 
28 This is possible, but uncertain,  because not all costs- as presented in Table I- were considered  
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length of stay between 20 and 25 days; and expected difference of mortality rate between 
8.58% and 18.18%. The average cost, LOS and mortality rate in the sample analyzed are 
respectively: 4679.37€; 12 days and 9.3% (see Appendix 4 and 5 for details).Considering the 
higher incidence rate of CLABSIs at national level (8%versus 1.7%), the relevance of these 
results is even greater. In SFXH the total extra financial burden ranges between 2,859,405€ 
and 4,001,696€,29 because costs are applied to only 1.7% of the patients and not 8%, as 
expected on average.   
This inefficiently used resources are even larger since they should this study did not account 
for all costs attributable to the morbidity (in particular none of the indirect costs). The public 
insurer should consider this waste of resources as a potential gain in efficiency of provision. 
In order to achieve a higher level of production, respecting the current financial constraints, 
different approaches are possible: positive (negative) trends may be prized (punished); or 
prevention campaigns financed. A new remuneration system may take into account the 
progress in the preventable HAIs’ control, incentivizing the progressive reduction of this 
morbidity or penalizing the increase of the same. If this is the case, the provider may create 
negative incentive: such as misreporting the onset of nosocomial infections (by reporting 
community infections); preventive over-administration of antibiotics or selection of less at-
risk patients. 30 These incentive scheme would be applicable only if accounting mechanisms 
are feasible: if physicians’ behavior is verifiable.  By financing prevention campaigns, the 
insurer would enhance the implementation of good practices for preventing the onset of 
CLABSIs or other nosocomial infections. If this is the intention, a cost-effectiveness analysis 
                                                     
29 Between 714,851.4€ and 1,000,424€ per year 
30 Graves and McGowan (2008) and Pronovost et al. (2008) 
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of the program must be available, in order to evaluate whether its implementation would be 
an efficiency gain: it may occur that a positive rate of infection is economically efficient.31  
This study attempts to create new information regarding the costs of CLABSIs in Portugal in 
order to better inform decision makers, nevertheless it must be supported by further research 
by infection control professionals; hospital epidemiologists, physicians, biostaticians, 
regulators and health economists.32    
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1. Definition of CLABSI 
Nosocomial bloodstream infections are registered in the Commission of Infections Control 
only if one of the following three criteria is applicable:  
1) One or more hemoculture positive results for a determined microorganism without relation 
to any other infection source.  
2) The patient presents:  
• Either fever, shivers or hypotension and  
• Signals and symptoms and laboratory confirmed proofs not related to any other infection 
source  
• In at least two hemocultures whose sample was collected in different points in time is 
identified the same usual skin contaminant (ex: difteróides -Corynebacterium spp-, Bacillus 
spp, Propionibacterium spp, Staphylococcus coagulase negative -including S. epidermidis-, 
Streptococcus group viridians, Aerococcus spp or Micrococcus spp); 
3) The patient with age inferior or equal to 1 year:  
• Presents at least two of the following symptoms: fever (>38ºC rectal), hypothermia (<37ºC 
rectal), apnoea or bradycardia 
• Signals and symptoms and laboratory confirmed proofs not related to any other infection 
source  
• In at least two hemocultures whose sample was collected in different points in time is 
identified the same usual skin contaminant (ex: difteróides -Corynebacterium spp-, Bacillus 
spp,Propionibacterium spp, Staphylococcus coagulase negative -including S. epidermidis-, 
Streptococcus group viridians, Aerococcus spp or Micrococcus spp); 
 





Daily costs per patient 
2009 2010 2011 2012 
Surgery 
42 225.4338 243.8328 226.8879 195.1717 Intermediate Care 
Unit Surgery 
Orthopedics 
33 246.2927 287.6434 354.8872 307.2037 Intermediate Care 
Unit Orthopedics  
Medicine III 25 287.4892 309.8867 322.7008 197.7955 
Medicine IV 36 218.1261 227.6094 263.9933 185.8002 
Hematology 13 460.343 400.9913 760.9247 386.3838 
ICU Polyvalent 8 784.9433 865.0998 956.8535 743.9505 
ICU Surgery 8 864.8287 893.7355 854.2299 618.5171 
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3. Specification of Attribution of ward to each general ward 
 Ward Ward code 
Surgery 
General Surgery 34001 
Intermediate Surgery Care 34002 
General Surgery other Hospital 36002; 36003; 38004 
Neurosurgery other Hospital 36014 
Vascular Surgery  36030 
Intermediate Surgery Care other Hospital 36036; 36039 
Cardiotorax Surgery other Hospital 36032; 38003 
Medicine 
Medicine III 34020 
Medicine IV 34006; 34021 
Medicine Intermediate Care Unit 36011;36012;36012;36013 
Medicine/orthopedics 34024;34025 
Vascular Celebral Accident Unit 34028; 34007 
Cardiology 34028 




Cardiology of other hospital 36001; 38001 
Orthopedics 
Orthopedics 34022 
Orthopedics Intermediate Care Unit 34023 
Orthopedics of other hospital 34097 
ICU 
Surgery Intensive Care Unit  34003 
Polyvalent Intensive Care Unit 34008 
Intensive Care Unit of other Hospital  36027 
Polyvalent Intensive Care Unit of other 
Hospital 38007 


















4. Variable LOS details 
 
5. Variable Mortality and Cost details 
 
 
 
 
